Ocumetics Technology Corp. (OTCFF)
USD 0.2
(0.0%)
USD 0.2
(0.0%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 945.32 Thousand CAD | 76.22% |
| 2022 | 536.45 Thousand CAD | -51.04% |
| 2021 | 1.09 Million CAD | 6006.87% |
| 2020 | 17.94 Thousand CAD | 86.34% |
| 2019 | 9629.00 CAD | -28.29% |
| 2018 | 13.42 Thousand CAD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 1.18 Million CAD | 25.11% |
| 2023 FY | 945.32 Thousand CAD | 76.22% |
| 2023 Q4 | 945.32 Thousand CAD | 35.1% |
| 2023 Q3 | 699.72 Thousand CAD | -5.73% |
| 2023 Q1 | 637.69 Thousand CAD | 18.87% |
| 2023 Q2 | 742.22 Thousand CAD | 16.39% |
| 2022 Q3 | 762.61 Thousand CAD | -1.46% |
| 2022 Q2 | 773.94 Thousand CAD | 7.97% |
| 2022 Q1 | 716.81 Thousand CAD | -5.83% |
| 2022 Q4 | 536.45 Thousand CAD | -29.66% |
| 2022 FY | 536.45 Thousand CAD | -51.04% |
| 2021 Q4 | 761.22 Thousand CAD | 12.94% |
| 2021 FY | 1.09 Million CAD | 6006.87% |
| 2021 Q3 | 674.03 Thousand CAD | 7156.23% |
| 2021 Q1 | 40.42 Thousand CAD | 125.32% |
| 2021 Q2 | 9289.00 CAD | -77.02% |
| 2020 Q3 | - CAD | -100.0% |
| 2020 Q4 | 17.94 Thousand CAD | 0.0% |
| 2020 Q2 | 142.01 Thousand CAD | 0.0% |
| 2020 FY | 17.94 Thousand CAD | 86.34% |
| 2019 FY | 9629.00 CAD | -28.29% |
| 2018 FY | 13.42 Thousand CAD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| American Medical Technologies Inc. | 2.34 Million USD | 59.771% |
| Ansell Limited | 1.32 Billion USD | 99.929% |
| Ansell Limited | 1.33 Billion USD | 99.929% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | 126.33 Million USD | 99.252% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | 943.17 Thousand USD | -0.229% |
| Psykey, Inc. | 2.47 Million USD | 61.79% |
| ConvaTec Group Plc | 2.01 Billion USD | 99.953% |
| ConvaTec Group Plc | 2.02 Billion USD | 99.953% |
| Encision Inc. | 1.98 Million USD | 52.352% |
| Golden Valley Development, Inc | - USD | -Infinity% |
| Hear AtLast Holdings, Inc. | 3.04 Million USD | 68.909% |
| Innovative MedTech Inc. | 6.13 Million USD | 84.591% |
| LifePoint, Inc. | 2.45 Million USD | 61.481% |
| Medite Cancer Diagnostics, Inc. | 10.18 Million USD | 90.715% |
| Paradigm Medical Industries, Inc. | 3.4 Million USD | 72.196% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | 3.04 Million USD | 68.907% |
| Reflect Scientific, Inc. | 776.32 Thousand USD | -21.769% |
| SmileDirectClub, Inc. | 982.26 Million USD | 99.904% |
| Sector 10, Inc. | 9.84 Million USD | 90.398% |
| Shandong Weigao Group Medical Polymer Company Limited | 1.35 Billion USD | 99.93% |
| SheerVision, Inc. | 1.43 Million USD | 33.958% |
| United Health Products, Inc. | 1.99 Million USD | 52.707% |
| Vasamed, Inc. | 1 Million USD | 5.965% |
| Wearable Health Solutions, Inc. | 3.8 Million USD | 75.125% |
| Yubo International Biotech Limited | 2.91 Million USD | 67.558% |